Literature DB >> 28457397

Parathyroidectomy in Persistent Post-transplantation Hyperparathyroidism - Single-center Experience.

C Meng1, P Martins2, J Frazão2, M Pestana2.   

Abstract

BACKGROUND: Hyperparathyroidism is a common complication in chronic kidney disease and might persist in up to 25% of patients after transplantation. In this setting, vitamin D analogues further aggravate persistent hypercalcemia and cinacalcet has not been approved for these patients, some of whom will require parathyroidectomy to correct post-transplantation hyperparathyroidism.
OBJECTIVES: In this single-center, retrospective study we aimed to analyze the long-term effect of parathyroidectomy on calcium, phosphorus, and parathyroid hormone (PTH) levels and its effect on allograft function in kidney transplantation patients submitted to parathyroidectomy. PATIENTS AND METHODS: Fifteen patients underwent parathyroidectomy between January 2005 and January 2015; median age 54 years old; 8 (53.3%) were receiving cinacalcet at the time of surgery. Pre-parathyroidectomy median values of intact PTH, calcium, and phosphorus were, respectively, 262 pg/mL, 10.8 mg/dL, and 2.4 mg/dL. Surgery consisted of uniglandular parathyroidectomy in 5 (33.3%) patients, biglandular in 4 (26.7%), and subtotal in 6 (40%). There was no surgery-related mortality.
RESULTS: Compared with baseline, there was a decrease of PTH (262 pg/mL vs. 106 pg/mL, P = .001), calcium, and phosphorus levels (10.8 mg/dL vs. 10.4 mg/dL, P = .3; 2.4 vs. 2.9 mg/dL, P = .05) 1 year after surgery; with normalization of serum calcium at the end of follow-up (10.8 mg/dL vs. 9.4 mg/dL, P = .04). A decrease in estimated glomerular filtration rate occurred 1 month post-surgery (62.7 mL/m vs. 49.7 mL/m, P = .006) but returned to baseline 1 year after surgery (62.7 mL/m vs. 60.8 mL/m, P = .73).
CONCLUSION: Parathyroidectomy appears to be a safe procedure and should be considered in kidney transplantation patients with persistent post-transplantation hyperparathyroidism. Although there was an acute estimated glomerular filtration rate decrease, we observed no long-term deterioration in allograft function.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28457397     DOI: 10.1016/j.transproceed.2017.01.067

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  3 in total

1.  Impact of parathyroidectomy on kidney graft function in post-transplant tertiary hyperparathyroidism: a comparative study.

Authors:  Samuel Frey; Thomas Goronflot; Claire Blanchard; Clarisse Kerleau; Pierre-Antoine Gourraud; Matthieu Wargny; Cécile Caillard; Maryvonne Hourmant; Lucile Figueres; Éric Mirallié
Journal:  Langenbecks Arch Surg       Date:  2022-05-21       Impact factor: 2.895

2.  Therapy for persistent hypercalcemic hyperparathyroidism post-renal transplant: cinacalcet versus parathyroidectomy.

Authors:  Gabriel Giollo Rivelli; Marcelo Lopes de Lima; Marilda Mazzali
Journal:  J Bras Nefrol       Date:  2020 Jul-Sep

3.  Surgery for Renal Hyperparathyroidism in the Era of Cinacalcet: A Single-Center Experience.

Authors:  M T Mogl; T Skachko; E M Dobrindt; P Reinke; C Bures; J Pratschke; N Rayes
Journal:  Scand J Surg       Date:  2020-01-06       Impact factor: 2.360

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.